Washed and Re-Washed Red Blood Cells Production

The contract pertains to the specialized production of washed and re-washed red blood cells designed for patients with hypersensitivities to plasma proteins and allergens, requiring precise processing protocols to ensure clinical safety. The service demands on-demand manufacturing to meet unpredictable patient needs, with strict adherence to a 24-hour shelf-life window, necessitating rapid turnaround and efficient logistical coordination. Production must comply with high standards of sterility and cellular integrity throughout the wash cycle to preserve transfusion efficacy while eliminating reactive components. This subcontract, issued under the 244-NETWORK Contract Office 4 within the Department of Veterans Affairs, falls under NAICS code 621991 for other miscellaneous ambulatory health care services. The solicitation opened on July 31, 2026, with responses due by August 10, 2026, indicating a tight timeline for qualified vendors to submit proposals. The place of performance and specific operational location are not detailed, but the nature of the service implies a need for proximity to transfusion centers or blood banking facilities capable of maintaining cold chain integrity and real-time inventory control to support the 24-hour viability requirement.